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Supplementary Figure Legends 
Supplementary Figure 1: Conservation of proline residues and degrees of transient 
helicity of WT and mutant p53TAD 
a) Multiple sequence alignment of vertebrate p53TADs. Conserved prolines flanking the 
Mdm2 binding site (red) are shown in orange. b) Extended random-coil α carbon 
chemical shift deviations (ΔδCα, black bars) and helical d2D plots (red) for WT and 
mutant p53TADs as determined by NMR spectroscopy. Asterisks denote sites of proline 
to alanine mutations. Grey shadings depict p53 residues involved in Mdm2 and 
RPA70/TFIIH binding. 
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Supplementary Figure 2: Backbone dynamics of p53TAD and affinity 
measurements for Mdm2 binding 
a) Hetero-nuclear NHNOE data for free WT and mutant p53TAD (aa1-73). Values are 
the average of three replicate experiments. Error bars denote standard deviations. b) 
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% helicity Kd (nM) ΔG (kcal/mol)
28 240 60 -9.1 0.2
64 25 3 -10.4 0.1


























Supplementary Figure 3: Binding characteristics of WT and mutant p53TAD to 
Mdm2  
 a) Extended panel of thermodynamic binding parameters of WT and mutant p53TAD-
Mdm2 interactions. b) Combined 1H, 15N chemical shift differences 
(Δδ  =[Δδ(1H)2+ (Δδ(15N)/5)2]1/2) of 15N isotope-labeled WT and mutant p53TAD (aa1-73) 
upon binding to unlabeled Mdm2. No p53TAD backbone amide chemical shifts greater 
than 0.25 p.p.m were detected outside the shown interaction region. c) Combined 1H, 15N 
chemical shift differences (Δδ) of 15N isotope-labeled Mdm2 (aa17-125) upon binding to 
unlabeled WT and P27A p53TAD. Residues experiencing chemical shift changes greater 
than 0.4 p.p.m are labeled and color-coded in shades of blue. Surface mapping identifies 
highly congruent binding effects of WT and P27A p53TAD on Mdm2 (pdb code: 1YCR). 
Mdm2 prolines are indicated. Asterisks denote sites of intermediate chemical exchange, 
line-broadening and absence of chemical shift information in the respective complexes. 
Note that despite the lack of data for these sites, their positions are conserved in both 
complexes. Bottom panel: Chemical shift difference (Δδ) mapping between WT and 
P27A p53TAD-Mdm2 complexes confirms similar binding modes and highlights minor 
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Supplementary Figure 4: Cell models to study WT and helical p53TAD mutants and 
their dynamics 
a) Hetero-nuclear NHNOE data for WT and P27A mutant p53TAD in complex with 
Mdm2. Sites of p53TAD prolines are indicated. Asterisks denote residues with very weak 
peak intensities in the bound state. b) Schematic overview of procedures used for 
shRNA-mediated repression of endogenous p53 and expression of Venus-tagged versions 
of WT and mutant p53. c) Bar graphs show clonal variations in WT and mutant p53 
mRNA expression levels in the different MCF7 cell clones as determined by RT-qPCR. 
Data are normalized to WT clone I, Actin serves as the internal standard. Error bars 
represent standard deviations. Western blot analysis of basal and DNA damaged-induced 
p53 levels for the different cell clones. (Uncropped Western blot images are shown in 
Supplementary Figure 10). d) Representative time series of live-cell fluorescence 
images showing oscillating protein levels of WT and P27A mutant p53. Arrows mark the 
same cell at each time point; the scale bar indicates 20 µm. 
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Supplementary Figure 5: Quantification of pulsed accumulation profiles of WT and 
mutant p53 cells 
Dynamic features were quantified from single cell trajectories and are indicated on the 
corresponding y-axes of the bar graphs. Error bars represent standard error of the mean 
and standard error of the proportion, respectively. n > 100 cells per condition. 
 
a






























(dot-blot analyses on equal amounts of WT, P27A and P3xA
p53TAD peptides, 100% Ser15 phosphorylated)
pSer15-antibody quality control on WT and mutant p53TAD epitopes
Supplementary Figure 6: Cellular dynamics and phosphorylation of WT and P27A, 
P3xA p53 
a) Time-resolved Western blots of WT and mutant p53 accumulation profiles upon DSB 
induction and correlation with Mdm2 protein levels. b) Time resolved Western blots of 
total and Ser15-phophorylated p53. Actin serves as the loading control in all cases. 
Bottom panel: Dot-blot analysis of anti-pSer15 antibody detection efficiency of P27A 
and P3xA mutated p53TAD epitopes. (Uncropped Western blot images are shown in 
Supplementary Figure 10). 
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Supplementary Figure 7: Phosphorylation and effects of Nutlin3a on WT and 
mutant p53 
 a) Time-resolved NMR measurements of initial Ser15 and Ser37 phosphorylation 
velocities of WT and mutant p53TAD with recombinant DNA-PK. Direct time-resolved 
NMR measurements of relative phosphorylation rates of WT and mutant p53TAD by 
endogenous kinases in MCF7 cell lysates in the absence (shRNA endog. p53, right part), 
or re-introduced presence of full-length, WT p53 (left part). Rates of WT p53TAD were 
normalized and mutant rates determined with respect to WT. All NMR experiments were 
carried out in duplicates. Error bars represent standard deviations. b) Exemplary single 
cell trajectories of WT p53 dynamics after treatment with different concentrations of 
Nutlin3a. c) Quantifications of cells displaying pulsatile versus sustained p53 
accumulations at different concentrations of Nutlin3a in WT and mutant backgrounds. 
p53 accumulations were considered ‘sustained’ if levels stayed above 67% of peak levels 
for the duration of the experiment. n > 60 cells per condition.  
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Supplementary Figure 8: Nutlin3a and MG132 effects, and p53 target gene 
expression  
a) Comparative analysis of the fraction of cells with induced p53 expression and 
amplitudes of p53 accumulations upon Nutlin3a and MG132 treatment. n > 60 cells per 
condition. b) Time evolution of p53 accumulation in cells expressing WT and mutant p53 
upon proteasome inhibition with MG132. Solid lines indicate the mean, shaded areas the 
standard deviations of accumulated responses. n > 60 cells per condition. c) Measured 
differences of Bax mRNA levels in cells carrying wt and mutant p53, before and 16 hours 
after DSB induction. Bax levels with background p53 after shRNA knockdown (black) 
and with endogenous p53 in non-manipulated MCF7 cells (grey). Error bars represent 
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Supplementary Figure 9: Altered target gene expression- and cell cycle-profiles of 
helical p53TAD mutants in response to DNA damage 
a) Widths of p53 pulses post damage in P27A and P3xA mutant backgrounds in the 
presence or absence of 20 µM Nutlin3a (added 60 min. after irradiation). Error bars 
represent standard error of the mean. n > 60 cells per condition. b) Measured p21 mRNA 
levels in cells carrying mutant p53 16 hours post DSB induction in the presence, or 
absence of 20 µM Nutlin3a, compared to levels before damage. Actin serves as the 
internal standard for mRNA quantifications. Error bars represent standard error of the 
mean. n > 60 cells per condition. c) Distributions of log2-fold changes of differentially 
expressed non-p53 target genes before and after DSB induction. Data are normalized to 
expression levels of each gene in WT p53 cells before irradiation (0 h). White lines 
indicate the median of distributions, boxes include data between the 25th and 75th 
percentile. Whiskers extend to maximum values that are within 1.5 times the interquartile 
range; crosses represent outliers. Samples were sequenced on two lanes (rapid run mode); 
sequencing depth was 250 million reads. d) Heat map of fold-differences in p53 target 
gene inductions 16 hours post DSB in WT and mutant cells as determined by genome-
wide RNAseq measurements. e) Summary of the fraction of G1 cells in WT, mutant and 
shRNA-depleted p53 cells. DNA contents measured by flow cytometry and cell stage 
distributions in shRNA-depleted p53 cells 16 hours post DSB. Actin serves as the internal 
standard for mRNA quantifications. Data is from triplicate experiments; error bars 
represent standard error of the mean.  
 
  
Supplementary Figure 10        Borcherds et al. 
uncropped Western blots Supplementary Figure 4c 
p53
Actin















WTclone I clone II
Supplementary Figure 10_2        Borcherds et al. 
uncropped Western blots Supplementary Figure 6b 
WT p53
clone I
P27A
clone I
p53
Actin
pSer15
P3xA
clone I
